MAPT and Alzheimer disease: In addition, the activation of these kinases - ERKs, JNKs, and p38 MAPK which all belong to MAPK serine-threonine kinase group [116, 117], has been demonstrated to promote tau phosphorylation and in turn, AD pathophysiological alterations [118].